Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screensPeter Larsson, Toshima Z. Parris|Scientific Reports|2020Cited by 220
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinomaToshima Z. Parris, Khalil Helou|International Journal of Cancer|2013Cited by 69